Global Head & Neck Cancer Drugs Market Trends and Forecast 2034
The global healthcare industry is witnessing a notable rise in the burden of head and neck cancers due to increasing tobacco consumption, alcohol use, ageing populations, and a higher prevalence of human papillomavirus (HPV) infections. Pharmaceutical companies are actively investing in innovative therapies, particularly immunotherapies and targeted treatments, to improve survival outcomes and...
0 Commentaires 0 Parts 62 Vue 0 Aperçu
Commandité